Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications. - Willisch P; Vázquez-Barreiro B; Plata A; Belmonte IC; Guardia G; Del Castillo-Acuña R; Francolini G; Franzese C; Henríquez JDS; Couñago F; López-Campos F (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026)